Beltran, Himisha
Harvard Medical School,
United States
2025 Rank: 44792
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1911 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44792 | 45661 |
| Total Cites | 23105 | 27491 |
| H-index | 66 | 72 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 141 | 142 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 3556 | 4152 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 5331 | 6116 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14711 | 16428 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.67 |
| Self-Citation Percentage |
15.95%
|
|
Beltran, Himisha
Dana-Farber Cancer Institute,
United States
2024 Rank: 49732
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2143 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49732 | 51792 |
| Total Cites | 19617 | 23545 |
| H-index | 63 | 65 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 133 | 134 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 3126 | 3681 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 4492 | 5210 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12648 | 14216 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.66 |
| Self-Citation Percentage |
16.68%
|
|
Beltran, Himisha
Dana-Farber Cancer Institute,
United States
2023 Rank: 58998
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 2508 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58998 | 61293 |
| Total Cites | 16226 | 19665 |
| H-index | 59 | 61 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 114 | 115 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 2729 | 3230 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 3625 | 4240 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10547 | 11943 |
| Ratio of Total Citations to Distinct Citing Papers | 1.54 | 1.65 |
| Self-Citation Percentage |
17.49%
|
|
Beltran, Himisha
Harvard Medical School,
United States
2022 Rank: 73673
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 3059 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73673 | 73747 |
| Total Cites | 12766 | 15674 |
| H-index | 49 | 54 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 97 | 98 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 2271 | 2713 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 2899 | 3436 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8504 | 9710 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.61 |
| Self-Citation Percentage |
18.55%
|
|
Beltran, Himisha
Dana-Farber Cancer Institute,
United States
2021 Rank: 76409
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 3140 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76409 | 81112 |
| Total Cites | 11308 | 13931 |
| H-index | 46 | 50 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 93 | 94 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 2089 | 2495 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 2562 | 3038 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7664 | 8802 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.58 |
| Self-Citation Percentage |
18.83%
|
|
Beltran, Himisha
Dana-Farber Cancer Institute,
United States
2020 Rank: 102325
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 4189 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102325 | 104869 |
| Total Cites | 7845 | 9752 |
| H-index | 39 | 42 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 76 | 76 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 1618 | 1938 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 1848 | 2194 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5448 | 6308 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.55 |
| Self-Citation Percentage |
19.55%
|
|